Drospirenone in the treatment of severe premenstrual cerebral edema in a woman with antiphospholipid syndrome, lateral sinus thrombosis, situs inversus and epileptic seizures

References

• Panay N, Studd J. Progesterone intolerance in the treatment of severe premenstrual syndrome. The 11th World Congress of Gynecological Endocrinology, 2004, Florence. The Parthenon Publishing Group, London 2004; 177
   Google Scholar
• Hammarback S, Ekholm U B, Backstrom T. Spontaneous anovulation causing appearance of cyclical symptoms in women with PMS. Acta Endocrinol 1991; 125: 132–137
   PubMedGoogle Scholar
• Studd J WW. Premenstrual syndrome. Br Med J 1979; 1: 410–415
   Google Scholar
• Backstrom T, Boyle H, Baird D T. Persistence of symptoms of premenstrual tension in hysterectomized women. Br J Obstet Gynaecol 1981; 88: 530–536
   PubMedGoogle Scholar
• Vujovic S. No evidence of premenstrual syndrome in female-to-male transsexuals. Gender Dysphoria 1992; 2: 56–68
   Google Scholar
• Poort S R, Rosental F R, Reitsma P H, Bertina R N. A common genetic variation in the 3-transected region of prothrombin gene is associated with elevated plasma prothrombin level and increase in venous thrombosis. Blood 1996; 88: 3698–3703
   PubMed Web of Science ®Google Scholar
• Soria J M, Almasy L, Souto J C, Tirado I, Borell M, Mateo J, Slifer S, Stone W, Blangero J, Fountcuberta J. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood 2000; 95: 2780–2785
   PubMedGoogle Scholar
• Carhuapoma J R, Mitsias P, Levine S R. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997; 28: 2363–2369
   PubMed Web of Science ®Google Scholar
• Moos R H. The development of a menstrual distress questionnaire. Psychosom Med 1968; 30: 853–867
   PubMed Web of Science ®Google Scholar
• Mortola J F, Girton L, Beck L, Yen S S. Diagnosis of premenstrual syndrome by a simple, prospective and reliable instrument: the calendar of premenstrual experience. Obstet Gynecol 1990; 76: 302–307
   PubMed Web of Science ®Google Scholar
• Leker R R, Steiner I. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol 1998; 55: 817–820
   PubMedGoogle Scholar
• Vujovic S. Ultrasongrafske i funkcionale karakteristike ovarijuma u žena sa predmenstrucionim sindromom [dissertation]. University of Beograd, Beograd 1991
   Google Scholar
• Redei E, Freeman E W. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocinology 1995; 20: 259–267
   PubMed Web of Science ®Google Scholar
• Hammaback S, Damber J E, Backstrom T. Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab 1989; 68: 125–130
   PubMedGoogle Scholar
• Backstrom T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J. Mood, sexuality, hormones and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med 1983; 45: 503–507
   PubMed Web of Science ®Google Scholar
• Smith M J, Schmidt P J, Su T -P, Rubinow D R. Gonadotropin releasing hormone-stimulated gonadotropin levels in women with premenstrual dysphoria. Gynecol Endocrinol 2004; 19: 335–343
   PubMed Web of Science ®Google Scholar
• Petitclerc M, Bedard P J, Di Paolo T. Progesterone releases dopamine in male and female rat striatum. A behavioural and microdialysis study. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 491–497
   PubMed Web of Science ®Google Scholar
• Sinchak K, Micevych P E. Progesterone blockade of estrogen activation of μ-opioid receptors regulates reproductive behaviour. J Neurosci 2001; 21: 5723–5729
   PubMed Web of Science ®Google Scholar
• Limmroth U, Lee W S, Moskowitz M A. GABA-A receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges. Br J Pharmacol 1996; 117: 99–104
   PubMed Web of Science ®Google Scholar
• Genazzani A R, Stomati M, Morittu A, Bernardi F, Monteleone P, Casarosa E, Gallo R, Salvestroni C, Luisi M. Progesterone, progestogens and the central nervous system. Hum Reprod 2000; 15(Suppl)14–27
   PubMedGoogle Scholar
• Walker R F, Wilson C A. Changes in hypothalamic serotonin associated with amplification of LH-surges by progesterone in rats. Neuroendocrinology 1983; 37: 200–205
   PubMed Web of Science ®Google Scholar
• Brzezinski A A, Wurtman J J, Wurtman R J, Gleason R, Greenfield J, Nader T. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obstet Gynecol 1990; 76: 296–301
   PubMed Web of Science ®Google Scholar
• Pearlstein T B, Stone A B. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994; 55: 332–335
   PubMed Web of Science ®Google Scholar
• Corney R H, Stanton R. A survey of 658 women who report symptoms of premenstrual syndrome. J Psychosom Res 1991; 35: 471–482
   PubMed Web of Science ®Google Scholar
• Oelkers W, Helmerhorst F M, Wuttke W. Effects of an oral contraceptive containing drospirenone on the rennin– angiotensin–aldosterone system in healthy female volunteers. Gynecol Endocrinol 2000; 16: 204–213
   Google Scholar
• Freeman E W, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, Zhang P, Patel H, Foegh M, PMS/PMDD Research Group. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med 2001; 10: 561–569
   PubMedGoogle Scholar
• Apter D, Borsos A, Baumgartner W, Melis G B, Vexiau-Robert D, Colligs-Hakert A, Palmer M, Kelly S. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general wellbeing and fluid-related symptoms. Eur J Contracept Reprod Health Care 2003; 8: 37–51
   PubMed Web of Science ®Google Scholar
• Baltatu O, Bade M. Brain rennin–angiotensin system. Neuroendocrinology 2003; 78: 253–259
   PubMedGoogle Scholar
• Nanaka E, Emoto N, Iheda K, Fukuya H, Rohman M S, Raharjo S B, Yagita K, Okamura H, Yokoyama M. Angiotensin II induces circadian gene expression of clock genes in culture of vascular smooth muscle cells. Circulation 2001; 104: 1746–1748
   PubMedGoogle Scholar
• Yamakawa H, Phillips M, Saavedra J M. Intracisternal administration of angiotensin II AT (1) receptor antisense oligodeoxynucleotides protects against cerebal ischemia in spontaneously hypertensive rats. Regul Pept 2003; 111: 117–122
   PubMedGoogle Scholar
• Eriksson K T, Simblad C, Lispo P, Modigh K, Andersch B. Serum levels of androgen are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 1992; 17: 195–204
   PubMed Web of Science ®Google Scholar
• Muhn P, Fuhrmann U, Fritzemeier K H, Krattenmacher R, Schillinger E. Drospirenone: a novel progestogen with antimineralocirticoid and antiandrogen activity. Ann N Y Acad Sci 1995; 761: 311–335
   PubMed Web of Science ®Google Scholar
• Vandenbroucke J P, Rosing J, Bloemenkamp K W, Middeldorp S, Helmerhorst F M, Bouma B N, Rosendaal F R. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001; 344: 1527–1535
   PubMed Web of Science ®Google Scholar